Press release
Leading Growth Driver in the Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market in 2025: Rising Skin Disease Prevalence Fuels Growth In The Topical Drugs CDMO Market Driver's Influence
Topical Drugs Contract Development And Manufacturing Organization (CDMO)
The rising incidence of skin diseases is anticipated to drive the growth of the topical drugs contract development and manufacturing organization (CDMO) market. Skin diseases are medical conditions affecting the skin, leading to symptoms like inflammation, itching, and lesions. This increase in skin diseases is linked to factors such as environmental pollution, UV radiation, genetic predispositions, lifestyle changes, and microbial infections. CDMOs specializing in topical drugs help mitigate skin disease prevalence by creating and producing targeted treatments that enhance the management and treatment of dermatological issues. For example, in January 2024, Cancer Australia reported a significant rise in skin melanoma cases from 15,628 in 2019 to 18,257 in 2023, with male cases increasing from 9,134 to 10,639 and female cases growing from 6,494 to 7,618. As such, the increasing occurrence of skin diseases is fueling the growth of the topical drugs CDMO market.
Get Your Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Report Here:
https://www.thebusinessresearchcompany.com/report/topical-drugs-contract-development-and-manufacturing-organization-cdmo-global-market-report
How will the growth rate of the topical drugs contract development and manufacturing organization (cdmo) market shape industry trends by 2034?
The topical drugs contract development and manufacturing organization (CDMO) market has experienced rapid growth. It is estimated to expand from $52.9 billion in 2024 to $61.69 billion in 2025, at a CAGR of 16.6%. The market's historical growth was driven by the prevalence of chronic diseases, advancements in drug delivery technologies, cost-effective outsourcing, regulatory requirements, and expansion in dermatology and cosmetics.
The topical drugs contract development and manufacturing organization (CDMO) market is anticipated to expand rapidly in the next few years, reaching $113.06 billion by 2029 at a CAGR of 16.4%. This growth will be fueled by the rise of personalized medicine, the expansion of biologics, increased investments in research and development, a growing prevalence of skin disorders, and advancements in manufacturing technologies. Prominent trends include heightened demand for innovative formulations, progress in drug delivery technologies, increased investment in dermatological research, greater outsourcing by pharmaceutical firms, a focus on personalized medicine, regulatory requirements necessitating specialized expertise, and a growing preference for over-the-counter (OTC) skincare products.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15942&type=smp
What trends are poised to drive the future success of the topical drugs contract development and manufacturing organization (cdmo) market?
Major companies in the topical drugs contract development and manufacturing organization (CDMO) market are focused on developing cutting-edge manufacturing facilities to maintain their market position. A state-of-the-art facility is one equipped with the latest technology and processes designed for the development and production of topical pharmaceutical products. For example, in November 2023, SOHM Inc., a US-based pharmaceutical company, opened a new CDMO GMP manufacturing facility in Carlsbad. The facility offers significant space for producing topical products, including a 2,500-square-foot storage area for finished goods. Initially, it can manufacture up to 500 gallons (1,892 liters) of topicals daily, with plans to expand capacity for soft-gel suppositories by early 2024.
Which primary segments of the topical drugs contract development and manufacturing organization (cdmo) market are driving growth and industry transformations?
The topical drugs contract development and manufacturing organization (CDMO) market covered in this report is segmented -
1) By Product Type: Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products
2) By Service Type: Contract Development, Contract Manufacturing
3) By Therapeutic Area: Dermatology, Pain Management, Wound Care, Ophthalmology, Other Therapeutic Areas
4) By End-Use: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Uses
Subsegments:
1) By Semi-Solid Formulations: Creams, Ointments, Gels, Pastes
2) By Liquid Formulations Drugs: Solutions, Suspensions, Emulsions, Lotions
3) By Solid Formulations: Powders, Tablets
4) By Transdermal Products: Patches
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15942
Which geographical regions are pioneering growth in the topical drugs contract development and manufacturing organization (cdmo) market?
Asia-Pacific was the largest region in the topical drugs contract development and manufacturing organization (CDMO) market in 2023. The regions covered in the topical drugs contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Who are the influential players reshaping the topical drugs contract development and manufacturing organization (cdmo) market landscape?
Major companies operating in the topical drugs contract development and manufacturing organization (CDMO) market are Evonik Industries AG, Eurofins Scientific SE, SGS SA, The Lubrizol Corporation, Lonza Group AG, Catalent Inc., Bora Pharmaceuticals Co. Ltd., Recipharm AB, Pierre Fabre S.A., Piramal Pharma Solutions, Cambrex Corporation, LTS Lohmann Therapie-Systeme AG, PCI Pharma Services, Famar S.A., Contract Pharmaceuticals Limited, UPM Pharmaceuticals Inc., CoreRx Inc., Halo Pharmaceutical Inc., Tapemark Company, Groupe PARIMA Inc., MedPharm Ltd., Tergus Pharma LLC, Dow Development Laboratories LLC, NextPharma Technologies Holding Limited, Tedor Pharma Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=15942&type=smp
What Is Covered In The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Global Market Report?
•Market Size Forecast: Examine the topical drugs contract development and manufacturing organization (cdmo) market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the topical drugs contract development and manufacturing organization (cdmo) market for a structured understanding.
•Key Players Overview: Analyze major players in the topical drugs contract development and manufacturing organization (cdmo) market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the topical drugs contract development and manufacturing organization (cdmo) market.
•Segment Contributions: Evaluate how different segments drive overall growth in the topical drugs contract development and manufacturing organization (cdmo) market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the topical drugs contract development and manufacturing organization (cdmo) market.
•Industry Challenges: Identify potential risks and obstacles affecting the topical drugs contract development and manufacturing organization (cdmo) market.
•Competitive Landscape: Review strategic developments in the topical drugs contract development and manufacturing organization (cdmo) market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Growth Driver in the Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market in 2025: Rising Skin Disease Prevalence Fuels Growth In The Topical Drugs CDMO Market Driver's Influence here
News-ID: 3941102 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for CDMO
Global Cmo And Cdmo Biotechnology Market Size by Application, Type, and Geograph …
According to Market Research Intellect, the global Cmo And Cdmo Biotechnology market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
Biologics and sophisticated medicines are driving the biotechnology industry for Contract Manufacturing Organizations (CMO) and Contract…
Evolving Market Trends In The Inhalation CDMO Industry: Strategic Collaborations …
The Inhalation CDMO Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Inhalation CDMO Market Size During the Forecast Period?
In recent times, the inhalation CDMO market has experienced significant growth. The market value is expected to increase from $2.08 billion in 2024…
What's Driving the Inhalation CDMO Market 2025-2034: Rising Respiratory Disorder …
How Is the Chondroplasty Market Projected to Grow, and What Is Its Market Size?
The chondroplasty market has seen strong growth in recent years. It will increase from $13.77 billion in 2024 to $14.68 billion in 2025 at a CAGR of 6.5%. This growth is attributed to the rise in sports-related injuries, patient preference for non-total joint replacement procedures, advances in postoperative care, healthcare provider training, and an increasing incidence of…
Lentiviral Vector (LVV) CDMO Services Market Delivering Cures: The Role of LVV C …
Lentiviral Vector (LVV) CDMO Services Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Lentiviral Vector (LVV) CDMO Services Market - (By Type (IIT Grade, IND Grade, Clinical Trial Grade, Commercial Production Grade), By Application (Biopharmaceutical Company, Academic Scientific Research Institution)), Trends, Industry Competition Analysis, Revenue and Forecast To…
Electronic Chemicals CDMO Market Fueling the Electronics Boom: The Rise of the E …
Electronic Chemicals CDMO Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Electronic Chemicals CDMO Market - (By Type (Metals and Pastes, Electronic Specialty Gases, Polymer Compounds, Others), By Application (Battery, Semiconductor, Integrated Circuit, Consumer Electronics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest…
Peptide CDMO Market Size 2024 to 2031.
Market Overview and Report Coverage
A Peptide CDMO (Contract Development and Manufacturing Organization) is a company that provides services for the development and manufacturing of peptides, which are short chains of amino acids used in various pharmaceutical and biotechnological applications.
The future outlook of the Peptide CDMO Market looks promising, with a projected growth rate of 15.10% during the forecasted period. This growth is fueled by the increasing demand for…
